Stock A176750 DUCHEMBIO CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company DuChemBIO Co.,Ltd.

Equities

A176750

KR7176750008

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
7,350 KRW -0.68% Intraday chart for DuChemBIO Co.,Ltd. +0.68% +33.64%
2020 Telix Pharmaceuticals Limited Enters into A Commercialisation and Partnership Agreement with Duchembio Co, Ltd CI
2020 Radiopharmaceutical Business Division of CareCamp Inc. agreed to acquire DuChemBIO Co.,Ltd. from Kim Jong-woo and others, in a reverse merger transaction for approximately KRW 210 billion. CI

Business Summary

DuChemBio Co Ltd is a Korea-based company principally engaged in the manufacture and sale of radiopharmaceuticals. The Company is engaged in the manufacture and sale of diagnostic radiopharmaceuticals such as radiopharmaceuticals for the diagnosis of Parkinson's disease, radiopharmaceuticals for the diagnosis of Alzheimer's disease, and radiopharmaceuticals for the diagnosis of brain tumors. In addition, the Company is engaged in the sale of computed tomography (CT) contrast agents and other products.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Radiopharmaceuticals
95.9 %
30,929 95.4 % 33,281 95.9 % +7.60%
Medical Equipment Lease
4.1 %
1,493 4.6 % 1,415 4.1 % -5.27%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.7 %
32,392 99.9 % 34,592 99.7 % +6.79%
North America
0.2 %
-- 60 0.2 % -
Asia
0.1 %
19 0.1 % 31 0.1 % +57.89%
Europe
0.0 %
11 0.0 % 13 0.0 % +19.62%

Managers

Managers TitleAgeSince
Jong-Woo Kim CEO
 Chief Executive Officer 56 06/02/06
Jae-Ki Park PSD
 President 70 01/13/01
Hyun-Joon Ha CTO
 Chief Tech/Sci/R&D Officer 65 -
Bong-Seok Kim PRN
 Corporate Officer/Principal 58 01/11/01

Members of the board

Members of the board TitleAgeSince
Gyeong-Ho Lee BRD
 Director/Board Member 74 29/22/29
Jong-Woo Kim CEO
 Chief Executive Officer 56 06/02/06
Bong-Seok Kim PRN
 Corporate Officer/Principal 58 01/11/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,025,220 9,563,965 ( 35.39 %) 273,787 ( 1.013 %) 35.39 %

Shareholders

NameEquities%Valuation
Geo-Young Corp. (Korea)
52.94 %
14,307,130 52.94 % 73 M ₩
Jong-Woo Kim
10.72 %
2,897,363 10.72 % 15 M ₩
DUCHEMBIO CO.,LTD.
1.013 %
273,787 1.013 % 1 M ₩

Holdings

NameEquities%Valuation
DUCHEMBIO CO.,LTD.
1.01%
 273,787 1.01% 1,403,254 $

Company contact information

DuChemBIO Co., Ltd.

6-7/F, Seobong Gallery 81 Wausan-ro

04041, Seoul

+

http://www.duchembio.com
address DuChemBIO Co.,Ltd.(A176750)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
DUCHEMBIO CO.,LTD. Stock DuChemBIO Co.,Ltd.
+33.64% 144M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.04% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.66% 231B
NOVARTIS AG Stock Novartis AG
+5.03% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.16% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A176750 Stock
  4. Company DuChemBIO Co.,Ltd.